{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:24:06Z","timestamp":1788539046749,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexcr.2026.115148","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:44:43Z","timestamp":1786171483000},"page":"115148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis in vitiligo and melanoma: Opposing susceptibilities, shared mechanisms, and therapeutic targets"],"prefix":"10.1016","volume":"462","author":[{"given":"Chunyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9988","key":"10.1016\/j.yexcr.2026.115148_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.yexcr.2026.115148_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.yexcr.2026.115148_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163806","article-title":"The prevalence of vitiligo: a meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2016.11.010","article-title":"Current and emerging treatments for vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijwd.2017.11.005","article-title":"Vitiligo: patient stories, self-esteem, and the psychological burden of disease","volume":"4","author":"Grimes","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib6","first-page":"160","article-title":"Clinical practice. Vitiligo","volume":"360","author":"Taieb","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.yexcr.2026.115148_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","article-title":"Vitiligo: an update on pathophysiology and treatment options","volume":"18","author":"Speeckaert","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview Part I","volume":"65","author":"Alikhan","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.yexcr.2026.115148_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","article-title":"Genetics of vitiligo","volume":"35","author":"Spritz","year":"2017","journal-title":"Dermatol. Clin."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115148_bib11","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/sj.jid.5700953","article-title":"Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population","volume":"127","author":"Jin","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.yexcr.2026.115148_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000131501","article-title":"The genetics of generalized vitiligo","volume":"10","author":"Spritz","year":"2008","journal-title":"Curr. Dir. Autoimmun."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115148_bib13","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"223","key":"10.1016\/j.yexcr.2026.115148_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115148_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jid.2016.10.048","article-title":"CXCR3 depleting antibodies prevent and reverse vitiligo in mice","volume":"137","author":"Richmond","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Investig Dermatol Symp Proc."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","article-title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","volume":"144","author":"Jimbow","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115148_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/pcmr.13101","article-title":"Trained immunity in the pathogenesis of vitiligo","volume":"36","author":"Post","year":"2023","journal-title":"Pigment Cell Melanoma Res."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115148_bib20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115148_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7784","key":"10.1016\/j.yexcr.2026.115148_bib23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"7784","key":"10.1016\/j.yexcr.2026.115148_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"issue":"7860","key":"10.1016\/j.yexcr.2026.115148_bib25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.yexcr.2026.115148_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"14","key":"10.1016\/j.yexcr.2026.115148_bib27","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.yexcr.2026.115148_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/Tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.yexcr.2026.115148_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12967-022-03566-6","article-title":"Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.yexcr.2026.115148_bib31","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/cells12060936","article-title":"The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.yexcr.2026.115148_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0749.2006.00333.x","article-title":"A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Dell'Anna","year":"2006","journal-title":"Pigment. Cell Res."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pcmr.12949","article-title":"An update on vitiligo pathogenesis","volume":"34","author":"Seneschal","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/pcmr.13032","article-title":"Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo","volume":"35","author":"Wu","year":"2022","journal-title":"Pigment Cell Melanoma Res."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib35","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/pcmr.12955","article-title":"The fate of melanocyte: mechanisms of cell death in vitiligo","volume":"34","author":"Wu","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.yexcr.2026.115148_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12864-024-10147-y","article-title":"Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing","volume":"25","author":"Zhang","year":"2024","journal-title":"BMC Genom."},{"issue":"1\u20132","key":"10.1016\/j.yexcr.2026.115148_bib38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib40","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbrc.2016.08.034","article-title":"CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.yexcr.2026.115148_bib41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115148_bib43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"issue":"7498","key":"10.1016\/j.yexcr.2026.115148_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"issue":"7146","key":"10.1016\/j.yexcr.2026.115148_bib46","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature05859","article-title":"RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"issue":"10244","key":"10.1016\/j.yexcr.2026.115148_bib47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","article-title":"Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial","volume":"396","author":"Rosmarin","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115148_bib48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","article-title":"Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure","volume":"77","author":"Liu","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115148_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.yexcr.2026.115148_bib50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115148_bib51","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/ja411006a","article-title":"Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models","volume":"136","author":"Skouta","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent. Sci."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115148_bib53","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","article-title":"Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers","volume":"16","author":"Soula","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib54","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","article-title":"Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state","volume":"26","author":"Magtanong","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","article-title":"Energy-stress-mediated AMPK activation inhibits ferroptosis","volume":"22","author":"Lee","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"9\u201310","key":"10.1016\/j.yexcr.2026.115148_bib57","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1101\/gad.314674.118","article-title":"Regulation of lipid peroxidation and ferroptosis in diverse species","volume":"32","author":"Conrad","year":"2018","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.yexcr.2026.115148_bib58","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"51","key":"10.1016\/j.yexcr.2026.115148_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1158\/1541-7786.MCR-19-0691","article-title":"A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer","volume":"18","author":"Yang","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115148_bib62","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","article-title":"The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity","volume":"20","author":"Xie","year":"2017","journal-title":"Cell Rep."},{"issue":"7545","key":"10.1016\/j.yexcr.2026.115148_bib63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.yexcr.2026.115148_bib64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib65","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","article-title":"Lipid peroxidation in cell death","volume":"482","author":"Gaschler","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","article-title":"Resolving the role of lipoxygenases in the initiation and execution of ferroptosis","volume":"4","author":"Shah","year":"2018","journal-title":"ACS Cent. Sci."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib67","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","article-title":"PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals","volume":"171","author":"Wenzel","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.yexcr.2026.115148_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006203","article-title":"Unsolved mysteries: how does lipid peroxidation cause ferroptosis?","volume":"16","author":"Feng","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.yexcr.2026.115148_bib69","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115148_bib70","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bmcl.2011.09.047","article-title":"Development of small-molecule probes that selectively kill cells induced to express mutant RAS","volume":"22","author":"Weiwer","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"7679","key":"10.1016\/j.yexcr.2026.115148_bib71","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib72","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115148_bib73","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0891-5849(02)01360-6","article-title":"The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults","volume":"34","author":"Yant","year":"2003","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115148_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012249","article-title":"Selenoproteins are essential for proper keratinocyte function and skin development","volume":"5","author":"Sengupta","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115148_bib75","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCRESAHA.113.279984","article-title":"Combined deficiency in glutathione peroxidase 4 and vitamin E causes multiorgan thrombus formation and early death in mice","volume":"113","author":"Wortmann","year":"2013","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115148_bib76","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12016-021-08884-z","article-title":"Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo","volume":"61","author":"Wang","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115148_bib77","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"16","key":"10.1016\/j.yexcr.2026.115148_bib78","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/dna.2023.0188","article-title":"The role of regulatory cell death in vitiligo","volume":"43","author":"Liu","year":"2024","journal-title":"DNA Cell Biol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115148_bib80","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/pcmr.13037","article-title":"The delicate relation between melanocytes and skin immunity: a game of hide and seek","volume":"35","author":"Speeckaert","year":"2022","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.yexcr.2026.115148_bib81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbrc.2021.05.010","article-title":"Baicalein inhibits RSL3-induced ferroptosis in melanocytes","volume":"561","author":"Yang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7664","key":"10.1016\/j.yexcr.2026.115148_bib82","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115148_bib83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1084\/jem.20140857","article-title":"T cell lipid peroxidation induces ferroptosis and prevents immunity to infection","volume":"212","author":"Matsushita","year":"2015","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115148_bib84","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/biof.1912","article-title":"NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer","volume":"49","author":"Panieri","year":"2023","journal-title":"Biofactors"},{"key":"10.1016\/j.yexcr.2026.115148_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108670","article-title":"Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo","volume":"696","author":"Lin","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115148_bib86","first-page":"1713","article-title":"Current status and progress in vitiligo treatment","volume":"51","author":"Lu","year":"2016","journal-title":"Acta Univ. Med. Anhui"},{"issue":"16","key":"10.1016\/j.yexcr.2026.115148_bib87","first-page":"2020","article-title":"Mechanism of Kebai mixture in treating vitiligo through SCF\/Kit\/MITF signaling pathway","volume":"36","author":"Fu","year":"2019","journal-title":"Chin J Mod Appl Pharm."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272600265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272600265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:08:51Z","timestamp":1788538131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448272600265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S001448272600265X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115148","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferroptosis in vitiligo and melanoma: Opposing susceptibilities, shared mechanisms, and therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115148"}}